Decoy Therapeutics Inc. (DCOY): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2022-11-10; 1-for-8, first reflected in a filing dated 2024-08-09; 1-for-15, first reflected in a filing dated 2025-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.44M
As of 2024-12-31
532.0K
As of 2026-06-30
23.81M2014-12-31: 2.22M2015-12-31: 15.74M2016-12-31: 16.77M2017-12-31: 17.80M2018-12-31: 2.03M2019-12-31: 4.51M2020-12-31: 23.81M2021-12-31: 1.81M2022-12-31: 2.26M2023-12-31: 492.3K2024-12-31: 1.44M1.44M
2014-12-31 Shares Outstanding (shares) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2024-12-311.44M+192.7%2025-03-21, Balance as of period end
2023-12-31492.3Kn/c2025-03-21, Balance as of period end
2022-12-312.26M+24.7%2024-03-22, Balance as of period end
2021-12-311.81Mn/c2023-03-27, Balance as of period end
2020-12-3123.81M+427.8%2022-03-25, Balance as of period end
2019-12-314.51M+121.9%2021-03-18, Balance as of period end
2018-12-312.03M-88.6%2020-03-23, Balance as of period end
2017-12-3117.80M+6.1%2019-03-06, Balance as of period end
2016-12-3116.77M+6.6%2018-03-07, Balance as of period end
2015-12-3115.74M+610.5%2017-03-08, Balance as of period end
2014-12-312.22Mn/a2016-03-08, Balance as of period end